COMBINED ANTIFUNGIC THERAPY.

摘要

A COMBINED ANTIFUNGAL THERAPY THAT UNDERSTANDS THE USE OF ANTIFUNGAL AGENTS KNOWN AS SUCH AS THE BLUES OR THE POLLINS IN COMBINATION WITH AN ANTIFUNGAL AGENT DERIVED FROM THE NEUMOCANDIN IS DESCRIBED. MORE PARTICULARLY, THE INVENTION REFERS TO A COMBINED ANTIFUNGAL THERAPY THAT UNDERSTANDS THE USE OF SUCH AZOLAS AS FLUCONAZOLA, VORICONAZOLA, ITRACONAZOLA, KETOCONAZOLA, MICONAZOLA, ER 30346, SCH 56592; POLES SUCH AS AMPHOTERICIN B, NISTATIN OR LIPOSOMIAL AND LIPID FORMS OF THE SAME AS ABELCET, AMBISOME AND AMFOCIL; NUCLEOTID INHIBITORS OF PURINE AND PYRIMIDINE SUCH AS FLUCITOSINE; OR POLYOXINS SUCH AS NICOMYCINES, IN PARTICULAR NICOMYCIN ZU OTHER INHIBITORS OF THE QUITINE, INHIBITORS OF THE EXTENSION FACTOR SUCH AS SORDARIN AND ANALOGS OF THE SAME, INHIBITORS OF THE MANAN, SUCH AS THE PREDAMICINES OF BERMACINES (BERMACTIVITY PRODUCTS) SUCH AS XMP.97 OR XMP.127 OR COMPLEX ANTIFUNGAL CARBOHYDRATE AGENTS SUCH AS CAN-296 IN COMBINATION WITH A NEUMOCANDIN DERIVATIVE AS DESCRIBED ABOVE.